Q4 2016 Holdings
Filed 2017-02-14 | 102 holdings | $87.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $21.3M | 1,050,000 | 24.4% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $20.5M | 3,237,734 | 23.5% |
| Axogen Inc(AXGN) | COM | 05463X106 | $16.5M | 1,838,225 | 19.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.4M | 943,433 | 11.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $10.2M | 375,000 | 11.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $5.3M | 373,643 | 6.1% |
| Acura Pharmaceuticals Inc(ACUR) | COM PAR | 00509L802 | $786.0K | 1,025,641 | 0.9% |
| Horizon Pharma PLC | SHS | G4617B105 | $144.9K | 8,956,988 | 0.2% |
| Nxstage Medical Inc | COM | 67072V103 | $111.6K | 4,258,196 | 0.1% |
| Avexis Inc | COM | 05366U100 | $106.8K | 2,236,701 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $104.4K | 4,654,447 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $103.7K | 928,192 | 0.1% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $78.3K | $82,600,000 | 0.1% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $69.6K | 1,838,829 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $67.4K | 1,766,378 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $62.5K | $45,000,000 | 0.1% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $61.2K | 1,743,229 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $54.6K | 3,424,676 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $54.6K | 751,298 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $53.2K | 2,020,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $51.7K | 1,842,415 | 0.1% |
| Endologix Inc | NOTE 2.250%12/1 | 29266SAA4 | $46.1K | $51,117,000 | 0.1% |
| Anthem Inc(ELV) | COM | 036752103 | $45.7K | 318,000 | 0.1% |
| Lannet Inc | COM | 516012101 | $44.3K | 2,007,551 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $42.3K | 4,072,809 | 0.0% |
| Wright MED Group Inc | NOTE 2.000% 2/1 | 98235TAE7 | $41.8K | $40,050,000 | 0.0% |
| Trinity Biotech Invt LTD | NOTE 4.000% 4/0 | 89643QAB4 | $40.4K | $48,000,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $40.4K | 198,000 | 0.0% |
| Universal Amern Corp New | COM | 91338E101 | $37.6K | 3,774,090 | 0.0% |
| Endologix Inc | NOTE 3.250%11/0 | 29266SAB2 | $35.4K | $40,500,000 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $34.1K | 603,643 | 0.0% |
| Isis Pharmaceuticals Inc del | NOTE 1.000%11/1 | 464337AJ3 | $33.8K | $33,186,000 | 0.0% |
| Healthways Inc | NOTE 1.500% 7/0 | 422245AB6 | $32.4K | $25,000,000 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $30.0K | 242,000 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $29.5K | $27,600,000 | 0.0% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $29.5K | 355,957 | 0.0% |
| Molina Healthcare Inc | DBCV 1.625% 8/1 | 60855RAD2 | $28.5K | $25,000,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $28.1K | 2,640,609 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $27.7K | 1,709,400 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $27.2K | 423,112 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $25.7K | 1,036,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $25.6K | 1,403,653 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $22.0K | 1,812,778 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $20.3K | 407,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $19.4K | 1,601,049 | 0.0% |
| Fluidigm Corp del | NOTE 2.750% 2/0 | 34385PAA6 | $19.2K | $27,715,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $18.6K | 302,027 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $18.6K | 1,496,675 | 0.0% |
| Mylan N VCall | SHS EURO | N59465109 | $17.2K | 450,000 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $17.0K | $16,500,000 | 0.0% |